Humanetics Corporation
Excelsior, MN Doing business as Humanetics Corp
- UEI
- MSRQYLLQLYQ5
- CAGE
- 4B2E0
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 261 School Ave #210, Excelsior, MN 55331, USA
- Website
- humaneticscorp.com
- Founded
- 1988
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of BIO 300 as a novel treatment for idiopathic pulmonary fibrosis - project summary idiopathic pulmonary… | National Heart Lung and Blood Institute | $596,948 | |
| Development of BIO 300 injectable suspension to treat radiation-induced lung injury | Defense Health Agency | $10,265,040 | |
| Covid-19 treatment with BIO 300 to mitigate covid-19 associated acute respiratory distress syndrome and related sequelae | Defense Health Agency | $1,329,513 | |
| Development of BIO 301 to prevent acute radiation syndrome and mitigate the delayed effects of acute radiation exposure | Defense Health Agency | $5,999,215 | |
| Definitive Contract HHSN272201800011C | National Institute of Allergy and Infectious Diseases | $10,299,171 |
About Humanetics Corporation
Humanetics Corp is a for-profit biopharmaceutical company that develops medical countermeasures to treat the effects of radiation exposure, lung disease, and other indications.
Through federal grants, Humanetics Corp has conducted research and development of therapeutic candidates including BIO 300 and BIO 301. These grants were awarded by agencies such as the National Institutes of Health, Department of Defense, and Department of the Army to support programs in areas like cardiovascular disease, chemical and biological defense, and military medical research and development. Specific activities funded include preclinical efficacy studies, clinical trials, formulation development, and regulatory planning for radiation mitigation treatments and COVID-19-associated lung therapies.
Humanetics Corp also holds an Other Transaction IDV from the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to develop an oral formulation of BIO 300. This $19.5 million IDV aims to produce BIO 300 oral tablets as an alternate delivery mechanism for the therapeutic. Work will involve necessary preclinical and clinical studies to achieve regulatory approval. Performance will occur at Humanetics facilities and partner sites. Task orders will fund discrete development projects over the IDV's period of performance.
Quick answers
What is Humanetics Corporation's UEI?
Humanetics Corporation's Unique Entity ID (UEI) in SAM.gov is MSRQYLLQLYQ5.
What is Humanetics Corporation's CAGE code?
Humanetics Corporation's CAGE code is 4B2E0.
What is Humanetics Corporation's primary NAICS code?
Humanetics Corporation's primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Humanetics Corporation located?
Humanetics Corporation's physical address in SAM.gov is 261 School Ave #210, Excelsior, MN 55331, USA.
Is Humanetics Corporation registered in SAM.gov?
Yes. Humanetics Corporation's SAM.gov registration is active through August 3, 2027.
What is Humanetics Corporation's most recent federal award?
Humanetics Corporation's most recent federal grant award is Development of BIO 300 as a novel treatment for idiopathic pulmonary fibrosis - project summary idiopathic pulmonary… (R43HL167432), from National Heart Lung and Blood Institute, on September 1, 2023.
On GovTribe
See Humanetics Corporation's full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors